(Q70671011)

English

5-N-acetylardeemin, a novel heterocyclic compound which reverses multiple drug resistance in tumor cells. II. Isolation and elucidation of the structure of 5-N-acetylardeemin and two congeners

scientific article published on 01 March 1993

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8478256%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

5-N-acetylardeemin, a novel heterocyclic compound which reverses multiple drug resistance in tumor cells. II. Isolation and elucidation of the structure of 5-N-acetylardeemin and two congeners (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8478256%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

multiple drug resistance

1 reference

based on heuristic

inferred from title

Neosartorya fischeri

1 reference

Aspergillus fischeri

1 reference

1 reference

15b-β-hydroxy-5-N-acetylardeemin

1 reference

1 reference

author name string

J E Hochlowski

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8478256%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

M M Mullally

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8478256%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

S G Spanton

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8478256%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

D N Whittern

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8478256%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

P Hill

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8478256%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

J B McAlpine

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8478256%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

publication date

1993

3 references

16 September 2022

16 September 2022

full work available at URL

https://www.jstage.jst.go.jp/article/antibiotics1968/46/3/46_3_380/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.46.380?email=unpaywall_01@example.com

The Journal of Antibiotics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8478256%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

46

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8478256%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8478256%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

380-386

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8478256%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

online access status

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.46.380?email=unpaywall_01@example.com

access restriction status

1 reference

based on heuristic

inferred from online access status

On the biosynthesis of asperlicin and the directed biosynthesis of analogs in Aspergillus alliaceus

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.46.380

Novel cholecystokinin antagonists from Aspergillus alliaceus. II. Structure determination of asperlicins B, C, D, and E

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.46.380

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.41.878

5-N-Acetylardeemin, a novel heterocyclic compound which reverses multiple drug resistance in tumor cells. I. Taxonomy and fermentation of the producing organism and biological activity.

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.46.380

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.46.374

Identifiers

10.7164/ANTIBIOTICS.46.380

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8478256%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8478256%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q70671011&oldid=2127453604"